{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T23:17:25Z","timestamp":1789773445983,"version":"4.0.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T00:00:00Z","timestamp":1736467200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Acta Diabetol"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:sec>\n            <jats:title>Aims<\/jats:title>\n            <jats:p>To assess the efficacy and safety of automated insulin delivery (AID) systems compared to standard care in managing glycaemic control during pregnancy in women with Type 1 Diabetes Mellitus (T1DM).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods<\/jats:title>\n            <jats:p>We searched MEDLINE, Cochrane Library, registries and conference abstracts up to June 2024 for randomized controlled trials (RCTs) and observational studies comparing AID to standard care in pregnant women with T1DM. We conducted random effects meta-analyses for % of 24-h time in range of 63\u2013140\u00a0mg\/dL (TIR), time in hyperglycaemia (&gt;\u2009140\u00a0mg\/dl and\u2009&gt;\u2009180\u00a0mg\/dL), hypoglycaemia (&lt;\u200963\u00a0mg\/dl and\u2009&lt;\u200954\u00a0mg\/dL), total insulin dose (units\/kg\/day), glycemic variability (%), changes in HbA1c (%), maternal and fetal outcomes.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results<\/jats:title>\n            <jats:p>Thirteen studies (450 participants) were included. AID significantly increased TIR (Mean difference, MD 7.01%, 95% CI 3.72\u201310.30) and reduced time in hyperglycaemia\u2009&gt;\u2009140\u00a0mg\/dL and\u2009&gt;\u2009180\u00a0mg\/dL (MD \u2013\u00a05.09%, 95% CI \u2013\u00a09.41 to \u2013\u00a00.78 and MD \u2013\u00a02.44%, 95% CI \u2013\u00a04.69 to \u2013\u00a00.20, respectively). Additionally, glycaemic variability was significantly reduced (MD \u2013\u00a01.66%, 95% CI \u2013\u00a02.73 to \u2013\u00a00.58). Other outcomes did not differ significantly.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion<\/jats:title>\n            <jats:p>AID systems effectively improve glycaemic control during pregnancy in women with T1DM by increasing TIR and reducing hyperglycaemia without any observed adverse short-term effects on maternal and fetal outcomes.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1007\/s00592-025-02446-x","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T09:14:58Z","timestamp":1736500498000},"page":"441-452","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Automated insulin delivery in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1007","volume":"62","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4827-2350","authenticated-orcid":false,"given":"Athina","family":"Stamati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasios","family":"Christoforidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,10]]},"reference":[{"key":"2446_CR1","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph191710846","author":"N Malaza","year":"2022","unstructured":"Malaza N, Masete M, Adam S, Dias S, Nyawo T, Pheiffer C (2022) A systematic review to compare adverse pregnancy outcomes in women with pregestational diabetes and gestational diabetes. Int J Environ Res Public Health. https:\/\/doi.org\/10.3390\/ijerph191710846","journal-title":"Int J Environ Res Public Health"},{"issue":"4","key":"2446_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/jne.12946","volume":"33","author":"SR Ladyman","year":"2021","unstructured":"Ladyman SR, Brooks VL (2021) Central actions of insulin during pregnancy and lactation. J Neuroendocrinol 33(4):1\u201313. https:\/\/doi.org\/10.1111\/jne.12946","journal-title":"J Neuroendocrinol"},{"issue":"6","key":"2446_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/ijerph19063684","volume":"19","author":"M Gojnic","year":"2022","unstructured":"Gojnic M et al (2022) Maternal and fetal outcomes among pregnant women with diabetes. Int J Environ Res Public Health 19(6):1\u20139. https:\/\/doi.org\/10.3390\/ijerph19063684","journal-title":"Int J Environ Res Public Health"},{"issue":"2","key":"2446_CR4","first-page":"S3","volume":"20","author":"C Byrne","year":"2020","unstructured":"Byrne C et al (2020) Using diabetes technology in pregnancy. Br J Diabetes 20(2):S3\u2013S44","journal-title":"Br J Diabetes"},{"issue":"3","key":"2446_CR5","doi-asserted-by":"publisher","first-page":"324","DOI":"10.2337\/dci23-0067","volume":"47","author":"HR Murphy","year":"2024","unstructured":"Murphy HR (2024) A diabetes pregnancy technology roadmap: the 2023 Norbert Freinkel award lecture. Diabetes Care 47(3):324\u2013330. https:\/\/doi.org\/10.2337\/dci23-0067","journal-title":"Diabetes Care"},{"issue":"5","key":"2446_CR6","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/j.amjms.2019.08.008","volume":"358","author":"ND Sora","year":"2019","unstructured":"Sora ND, Shashpal F, Bond EA, Jenkins AJ (2019) Insulin pumps: review of technological advancement in diabetes management. Am J Med Sci 358(5):326\u2013331. https:\/\/doi.org\/10.1016\/j.amjms.2019.08.008","journal-title":"Am J Med Sci"},{"issue":"7","key":"2446_CR7","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1016\/S2213-8587(23)00116-X","volume":"11","author":"K Benhalima","year":"2023","unstructured":"Benhalima K et al (2023) Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets. Lancet Diabetes Endocrinol 11(7):490\u2013508. https:\/\/doi.org\/10.1016\/S2213-8587(23)00116-X","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"2","key":"2446_CR8","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1210\/endrev\/bnac022","volume":"44","author":"M Phillip","year":"2023","unstructured":"Phillip M et al (2023) Consensus recommendations for the use of automated insulin delivery technologies in clinical practice. Endocr Rev 44(2):254\u2013280. https:\/\/doi.org\/10.1210\/endrev\/bnac022","journal-title":"Endocr Rev"},{"key":"2446_CR9","doi-asserted-by":"publisher","DOI":"10.1111\/1753-0407.13558","author":"Y Gong","year":"2024","unstructured":"Gong Y et al (2024) Continuous subcutaneous insulin infusion versus multiple daily injection therapy in pregnant women with type 1 diabetes. J Diabetes. https:\/\/doi.org\/10.1111\/1753-0407.13558","journal-title":"J Diabetes"},{"issue":"8","key":"2446_CR10","doi-asserted-by":"publisher","DOI":"10.1016\/j.jdiacomp.2024.108795","volume":"38","author":"A Munda","year":"2024","unstructured":"Munda A, Kovacic C, Pongrac-Barlovic D (2024) Real-world data on the minimed 780g advanced hybrid closed-loop system use during type 1 diabetes pregnancy: one centre observational study. J Diabetes Complicat 38(8):108795. https:\/\/doi.org\/10.1016\/j.jdiacomp.2024.108795","journal-title":"J Diabetes Complicat"},{"issue":"46","key":"2446_CR11","doi-asserted-by":"publisher","first-page":"80679","DOI":"10.18632\/oncotarget.20952","volume":"8","author":"SF Lin","year":"2017","unstructured":"Lin SF, Kuo CF, Chiou MJ, Chang SH (2017) Maternal and fetal outcomes of pregnant women with type 1 diabetes, a national population study. Oncotarget 8(46):80679\u201380687. https:\/\/doi.org\/10.18632\/oncotarget.20952","journal-title":"Oncotarget"},{"issue":"5","key":"2446_CR12","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1007\/s13300-023-01394-5","volume":"14","author":"S Peacock","year":"2023","unstructured":"Peacock S, Frizelle I, Hussain S (2023) A systematic review of commercial hybrid closed-loop automated insulin delivery systems. Diabetes Ther 14(5):839\u2013855. https:\/\/doi.org\/10.1007\/s13300-023-01394-5","journal-title":"Diabetes Ther"},{"key":"2446_CR13","unstructured":"\u201cRohatgi A. WebPlotDigitizer Pacifica, California, USA 2021; 2021 [07\/11\/2021]. Version: 4.5. Available from: https:\/\/automeris.io\/WebPlotDigitizer\u201d."},{"key":"2446_CR14","unstructured":"Higgins JPT, Li T (2023) Chapter 6: Choosing effect measures and computing estimates of effect. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). [Online]. Available: Available from www.training.cochrane.org\/handbook.%0A%0A"},{"key":"2446_CR15","unstructured":"Deeks JJ, Higgins JPT (2023) Chapter 10: Analysing data and undertaking meta-analyses. In: Higgins JPT, Thomas J, Chandler J, Cumpston M, Li T, Page MJ, Welch VA (eds). Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (updated August 2023). [Online]. Available: Available from www.training.cochrane.org\/handbook."},{"key":"2446_CR16","doi-asserted-by":"publisher","first-page":"83","DOI":"10.2337\/dc22-S006","volume":"45","author":"American Diabetes Association Professional Practice Committee","year":"2022","unstructured":"American Diabetes Association Professional Practice Committee, American Diabetes Association Professional Practice Committee (2022) Glycemic targets: standards of medical care in diabetes 2022. Diabetes Care 45:83\u201396","journal-title":"Diabetes Care"},{"key":"2446_CR17","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/bmj.i4919","volume":"355","author":"JA Sterne","year":"2016","unstructured":"Sterne JA et al (2016) ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ (Online) 355:4\u201310. https:\/\/doi.org\/10.1136\/bmj.i4919","journal-title":"BMJ (Online)"},{"key":"2446_CR18","unstructured":"Sterne JAC, Hern\u00e1n MA, McAleenan A, Reeves BC (2023) Chapter 25: Assessing risk of bias in a non-randomized study. Cochrane,\u201d Cochrane h., L. In: Higgins JPT, Thomas J, Chandler J, Cumpston M and W. V. (eds) T, Page MJ, Eds., Cochrane. [Online]. Available: Available from www.training.cochrane.org\/handbook"},{"issue":"4","key":"2446_CR19","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1016\/j.jclinepi.2010.04.026","volume":"64","author":"G Guyatt","year":"2011","unstructured":"Guyatt G et al (2011) GRADE guidelines: 1. Introduction - GRADE evidence profiles and summary of findings tables. J Clin Epidemiol 64(4):383\u2013394. https:\/\/doi.org\/10.1016\/j.jclinepi.2010.04.026","journal-title":"J Clin Epidemiol"},{"issue":"12","key":"2446_CR20","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.2337\/dc11-1430","volume":"34","author":"HR Murphy","year":"2011","unstructured":"Murphy HR et al (2011) Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care 34(12):2527\u20132529. https:\/\/doi.org\/10.2337\/dc11-1430","journal-title":"Diabetes Care"},{"issue":"6","key":"2446_CR21","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1016\/S2213-8587(24)00089-5","volume":"12","author":"K Benhalima","year":"2024","unstructured":"Benhalima K et al (2024) Comparing advanced hybrid closed loop therapy and standard insulin therapy in pregnant women with type 1 diabetes (CRISTAL): a parallel-group, open-label, randomised controlled trial. Lancet Diabetes Endocrinol 12(6):390\u2013403. https:\/\/doi.org\/10.1016\/S2213-8587(24)00089-5","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"8","key":"2446_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1089\/dia.2024.0012","volume":"26","author":"S Polsky","year":"2024","unstructured":"Polsky S et al (2024) Randomized trial of assisted hybrid closed-loop therapy versus sensor-augmented pump therapy in pregnancy. Diabetes Technol Ther 26(8):1\u20139. https:\/\/doi.org\/10.1089\/dia.2024.0012","journal-title":"Diabetes Technol Ther"},{"issue":"17","key":"2446_CR23","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1056\/nejmoa2303911","volume":"389","author":"TTM Lee","year":"2023","unstructured":"Lee TTM et al (2023) Automated insulin delivery in women with pregnancy complicated by type 1 diabetes. N Engl J Med 389(17):1566\u20131578. https:\/\/doi.org\/10.1056\/nejmoa2303911","journal-title":"N Engl J Med"},{"issue":"7","key":"2446_CR24","doi-asserted-by":"publisher","first-page":"1391","DOI":"10.2337\/dc17-2534","volume":"41","author":"ZA Stewart","year":"2018","unstructured":"Stewart ZA et al (2018) Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial. Diabetes Care 41(7):1391\u20131399. https:\/\/doi.org\/10.2337\/dc17-2534","journal-title":"Diabetes Care"},{"issue":"7","key":"2446_CR25","doi-asserted-by":"publisher","first-page":"644","DOI":"10.1056\/nejmoa1602494","volume":"375","author":"ZA Stewart","year":"2016","unstructured":"Stewart ZA et al (2016) Closed-loop insulin delivery during pregnancy in women with type 1 diabetes. N Engl J Med 375(7):644\u2013654. https:\/\/doi.org\/10.1056\/nejmoa1602494","journal-title":"N Engl J Med"},{"key":"2446_CR26","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2023.110800","volume":"202","author":"L Albert","year":"2023","unstructured":"Albert L et al (2023) Off-label use of an automated insulin delivery system in pregnant women with type 1 diabetes. Diabetes Res Clin Pract 202:110800. https:\/\/doi.org\/10.1016\/j.diabres.2023.110800","journal-title":"Diabetes Res Clin Pract"},{"issue":"7","key":"2446_CR27","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1089\/dia.2023.0031","volume":"25","author":"AR Dodesini","year":"2023","unstructured":"Dodesini AR et al (2023) Real-world insulin treatment in pregnant women with type 1 diabetes using an advanced hybrid closed-loop system. Diabetes Technol Ther 25(7):516\u2013518. https:\/\/doi.org\/10.1089\/dia.2023.0031","journal-title":"Diabetes Technol Ther"},{"issue":"12","key":"2446_CR28","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1089\/dia.2023.0267","volume":"25","author":"C Guibert","year":"2023","unstructured":"Guibert C et al (2023) MiniMedTM 780G advanced hybrid closed-loop system study in pregnant women with type 1 diabetes. Diabetes Technol Ther 25(12):893\u2013901. https:\/\/doi.org\/10.1089\/dia.2023.0267","journal-title":"Diabetes Technol Ther"},{"issue":"7","key":"2446_CR29","doi-asserted-by":"publisher","first-page":"1425","DOI":"10.2337\/dc23-0173","volume":"46","author":"CJ Levy","year":"2023","unstructured":"Levy CJ et al (2023) At-home use of a pregnancy-specific zone-MPC closed-loop system for pregnancies complicated by type 1 diabetes: a single-arm, observational multicenter study. Diabetes Care 46(7):1425\u20131431. https:\/\/doi.org\/10.2337\/dc23-0173","journal-title":"Diabetes Care"},{"key":"2446_CR30","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02315-z","author":"R Fresa","year":"2024","unstructured":"Fresa R et al (2024) An automated insulin delivery system from pregestational care to postpartum in women with type 1 diabetes: preliminary experience with telemedicine in 6 patients. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-024-02315-z","journal-title":"Acta Diabetol"},{"issue":"1","key":"2446_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.7759\/cureus.52369","volume":"16","author":"N Nandam","year":"2024","unstructured":"Nandam N et al (2024) Tandem T: slim X2 insulin pump use in clinical practice among pregnant individuals with type 1 diabetes: a retrospective observational cohort study. Cureus 16(1):1\u201312. https:\/\/doi.org\/10.7759\/cureus.52369","journal-title":"Cureus"},{"key":"2446_CR32","doi-asserted-by":"publisher","DOI":"10.1089\/dia.2023.0594","author":"C Quir\u00f3s","year":"2024","unstructured":"Quir\u00f3s C et al (2024) Real-world evidence of off-label use of commercially automated insulin delivery systems compared to multiple daily insulin injections in pregnancies complicated by type 1 diabetes. Diabetes Technol Ther. https:\/\/doi.org\/10.1089\/dia.2023.0594","journal-title":"Diabetes Technol Ther"},{"issue":"2","key":"2446_CR33","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/dom.15357","volume":"26","author":"M Lei","year":"2024","unstructured":"Lei M et al (2024) Effect of artificial pancreas system use on glycaemic control among pregnant women with type 1 diabetes mellitus: a meta-analysis of randomized controlled trials. Diabetes Obes Metab 26(2):673\u2013681. https:\/\/doi.org\/10.1111\/dom.15357","journal-title":"Diabetes Obes Metab"},{"key":"2446_CR34","doi-asserted-by":"publisher","DOI":"10.1007\/s00592-024-02284-3","author":"T Teixeira","year":"2024","unstructured":"Teixeira T et al (2024) Efficacy of automated insulin delivery in pregnant women with type 1 diabetes: a meta-analysis and trial sequential analysis of randomized controlled trials. Acta Diabetol. https:\/\/doi.org\/10.1007\/s00592-024-02284-3","journal-title":"Acta Diabetol"},{"issue":"3","key":"2446_CR35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/life13030783","volume":"13","author":"M Bassi","year":"2023","unstructured":"Bassi M et al (2023) Automated insulin delivery (AID) systems: use and efficacy in children and adults with type 1 diabetes and other forms of diabetes in Europe in early 2023. Life 13(3):1\u201325. https:\/\/doi.org\/10.3390\/life13030783","journal-title":"Life"},{"issue":"7","key":"2446_CR36","doi-asserted-by":"publisher","first-page":"944","DOI":"10.3390\/pharmaceutics16070944","volume":"16","author":"MTI Rimon","year":"2024","unstructured":"Rimon MTI, Hasan MW, Hassan MF, Cesmeci S (2024) Advancements in insulin pumps: a comprehensive exploration of insulin pump systems, technologies, and future directions. Pharmaceutics 16(7):944. https:\/\/doi.org\/10.3390\/pharmaceutics16070944","journal-title":"Pharmaceutics"},{"issue":"5","key":"2446_CR37","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1210\/endrev\/bnab007","volume":"42","author":"S Schneeweiss","year":"2021","unstructured":"Schneeweiss S, Patorno E (2021) Conducting real-world evidence studies on the clinical outcomes of diabetes treatments. Endocr Rev 42(5):658\u2013690. https:\/\/doi.org\/10.1210\/endrev\/bnab007","journal-title":"Endocr Rev"},{"issue":"5","key":"2446_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1089\/dia.2022.0540","volume":"25","author":"ED Szmuilowicz","year":"2023","unstructured":"Szmuilowicz ED, Levy CJ, Buschur EO (2023) Expert guidance on off-label use of hybrid closed-loop therapy in pregnancies complicated by diabetes. Diabetes Technol Ther 25(5):363\u2013373. https:\/\/doi.org\/10.1089\/dia.2022.0540","journal-title":"Diabetes Technol Ther"},{"issue":"8","key":"2446_CR39","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1111\/dme.13988","volume":"36","author":"JM Yamamoto","year":"2019","unstructured":"Yamamoto JM et al (2019) Maternal glycaemic control and risk of neonatal hypoglycaemia in type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial. Diabet Med 36(8):1046\u20131053. https:\/\/doi.org\/10.1111\/dme.13988","journal-title":"Diabet Med"},{"issue":"January","key":"2446_CR40","doi-asserted-by":"publisher","first-page":"S254","DOI":"10.2337\/dc23-S015","volume":"46","author":"NA Elsayed","year":"2023","unstructured":"Elsayed NA et al (2023) 15. Management of diabetes in pregnancy: standards of care in diabetes\u20142023. Diabetes Care 46(January):S254\u2013S266. https:\/\/doi.org\/10.2337\/dc23-S015","journal-title":"Diabetes Care"},{"issue":"January","key":"2446_CR41","doi-asserted-by":"publisher","first-page":"S165","DOI":"10.2337\/dc19-S014","volume":"42","author":"American Diabetes Association","year":"2019","unstructured":"American Diabetes Association (2019) 14. Management of diabetes in pregnancy: standards of medical care in diabetes\u20142019. Diabetes Care 42(January):S165\u2013S172. https:\/\/doi.org\/10.2337\/dc19-S014","journal-title":"Diabetes Care"},{"issue":"10","key":"2446_CR42","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1089\/dia.2021.0073","volume":"23","author":"D Tundidor","year":"2021","unstructured":"Tundidor D et al (2021) Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes. Diabetes Technol Ther 23(10):710\u2013714. https:\/\/doi.org\/10.1089\/dia.2021.0073","journal-title":"Diabetes Technol Ther"},{"issue":"3","key":"2446_CR43","doi-asserted-by":"publisher","first-page":"446","DOI":"10.1007\/s00125-009-1633-z","volume":"53","author":"A Garc\u00eda-Patterson","year":"2010","unstructured":"Garc\u00eda-Patterson A, Gich I, Amini SB, Catalano PM, De Leiva A, Corcoy R (2010) Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction. Diabetologia 53(3):446\u2013451. https:\/\/doi.org\/10.1007\/s00125-009-1633-z","journal-title":"Diabetologia"},{"issue":"12","key":"2446_CR44","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1089\/dia.2021.0112","volume":"23","author":"G O\u2019Malley","year":"2021","unstructured":"O\u2019Malley G et al (2021) Longitudinal observation of insulin use and glucose sensor metrics in pregnant women with type 1 diabetes using continuous glucose monitors and insulin pumps: the LOIS-P study. Diabetes Technol Ther 23(12):807\u2013817. https:\/\/doi.org\/10.1089\/dia.2021.0112","journal-title":"Diabetes Technol Ther"},{"issue":"1","key":"2446_CR45","doi-asserted-by":"publisher","first-page":"9","DOI":"10.2337\/dc07-1066","volume":"31","author":"LR Nielsen","year":"2008","unstructured":"Nielsen LR, Pedersen-Bjergaard U, Thorsteinsson B, Johansen M, Damm P, Mathiesen ER (2008) Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control. Diabetes Care 31(1):9\u201314. https:\/\/doi.org\/10.2337\/dc07-1066","journal-title":"Diabetes Care"},{"issue":"11","key":"2446_CR46","doi-asserted-by":"publisher","first-page":"3137","DOI":"10.1210\/clinem\/dgac464","volume":"107","author":"M Dhanasekaran","year":"2022","unstructured":"Dhanasekaran M et al (2022) Diabetic ketoacidosis in pregnancy: clinical risk factors, presentation, and outcomes. J Clin Endocrinol Metab 107(11):3137\u20133143. https:\/\/doi.org\/10.1210\/clinem\/dgac464","journal-title":"J Clin Endocrinol Metab"},{"key":"2446_CR47","doi-asserted-by":"publisher","DOI":"10.2337\/dc24-0725","author":"N Atta","year":"2024","unstructured":"Atta N, Ezeoke A, Petry CJ, Kusinski LC (2024) Associations of high BMI and excessive gestational weight gain with pregnancy outcomes in women with type 1 diabetes: a systematic review and meta-analysis. Diabetes Care. https:\/\/doi.org\/10.2337\/dc24-0725","journal-title":"Diabetes Care"},{"issue":"10","key":"2446_CR48","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm9103223","volume":"9","author":"E Wender-Ozegowska","year":"2020","unstructured":"Wender-Ozegowska E, Gutaj P, Mantaj U, Kornacki J, Ozegowski S, Zawiejska A (2020) Pregnancy outcomes in women with long-duration type 1 diabetes\u201425 years of experience. J Clin Med 9(10):1\u201320. https:\/\/doi.org\/10.3390\/jcm9103223","journal-title":"J Clin Med"},{"issue":"4","key":"2446_CR49","doi-asserted-by":"publisher","first-page":"1039","DOI":"10.1097\/00006250-200610000-00046","volume":"108","author":"American College of Obstetricians and Gynecologists","year":"2006","unstructured":"American College of Obstetricians and Gynecologists (2006) ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists number 76, October 2006: postpartum hemorrhage. Obstet Gynecol 108(4):1039\u20131047. https:\/\/doi.org\/10.1097\/00006250-200610000-00046. (PMID: 17012482)","journal-title":"Obstet Gynecol"}],"container-title":["Acta Diabetologica"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00592-025-02446-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00592-025-02446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,6]],"date-time":"2025-05-06T05:06:23Z","timestamp":1746507983000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00592-025-02446-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,10]]},"references-count":49,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2025,4]]}},"alternative-id":["2446"],"URL":"https:\/\/doi.org\/10.1007\/s00592-025-02446-x","relation":{},"ISSN":["1432-5233"],"issn-type":[{"value":"1432-5233","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,10]]},"assertion":[{"value":"7 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 December 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"A.S. and A.C. declare that they have no relevant or material financial interests that relate to the research described in this paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}